20-17615941-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001365613.2(RRBP1):c.3936G>A(p.Thr1312Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00189 in 1,610,206 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 19 hom., cov: 34)
Exomes 𝑓: 0.0010 ( 18 hom. )
Consequence
RRBP1
NM_001365613.2 synonymous
NM_001365613.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.42
Genes affected
RRBP1 (HGNC:10448): (ribosome binding protein 1) This gene encodes a ribosome-binding protein of the endoplasmic reticulum (ER) membrane. Studies suggest that this gene plays a role in ER proliferation, secretory pathways and secretory cell differentiation, and mediation of ER-microtubule interactions. Alternative splicing has been observed and protein isoforms are characterized by regions of N-terminal decapeptide and C-terminal heptad repeats. Splicing of the tandem repeats results in variations in ribosome-binding affinity and secretory function. The full-length nature of variants which differ in repeat length has not been determined. Pseudogenes of this gene have been identified on chromosomes 3 and 7, and RRBP1 has been excluded as a candidate gene in the cause of Alagille syndrome, the result of a mutation in a nearby gene on chromosome 20p12. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 20-17615941-C-T is Benign according to our data. Variant chr20-17615941-C-T is described in ClinVar as [Benign]. Clinvar id is 710613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.42 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0101 (1532/152332) while in subpopulation AFR AF = 0.0349 (1450/41576). AF 95% confidence interval is 0.0334. There are 19 homozygotes in GnomAd4. There are 703 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 19 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RRBP1 | NM_001365613.2 | c.3936G>A | p.Thr1312Thr | synonymous_variant | Exon 22 of 25 | ENST00000377813.6 | NP_001352542.1 | |
RRBP1 | NM_001042576.2 | c.2637G>A | p.Thr879Thr | synonymous_variant | Exon 23 of 26 | NP_001036041.2 | ||
RRBP1 | NM_004587.3 | c.2637G>A | p.Thr879Thr | synonymous_variant | Exon 22 of 25 | NP_004578.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0101 AC: 1531AN: 152214Hom.: 19 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
1531
AN:
152214
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00271 AC: 672AN: 248380 AF XY: 0.00208 show subpopulations
GnomAD2 exomes
AF:
AC:
672
AN:
248380
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00103 AC: 1507AN: 1457874Hom.: 18 Cov.: 31 AF XY: 0.000867 AC XY: 629AN XY: 725424 show subpopulations
GnomAD4 exome
AF:
AC:
1507
AN:
1457874
Hom.:
Cov.:
31
AF XY:
AC XY:
629
AN XY:
725424
Gnomad4 AFR exome
AF:
AC:
1072
AN:
33472
Gnomad4 AMR exome
AF:
AC:
81
AN:
44702
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26132
Gnomad4 EAS exome
AF:
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
AC:
26
AN:
86248
Gnomad4 FIN exome
AF:
AC:
0
AN:
49606
Gnomad4 NFE exome
AF:
AC:
160
AN:
1111886
Gnomad4 Remaining exome
AF:
AC:
163
AN:
60364
Heterozygous variant carriers
0
73
146
220
293
366
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0101 AC: 1532AN: 152332Hom.: 19 Cov.: 34 AF XY: 0.00944 AC XY: 703AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
1532
AN:
152332
Hom.:
Cov.:
34
AF XY:
AC XY:
703
AN XY:
74490
Gnomad4 AFR
AF:
AC:
0.0348759
AN:
0.0348759
Gnomad4 AMR
AF:
AC:
0.0036587
AN:
0.0036587
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000147016
AN:
0.000147016
Gnomad4 OTH
AF:
AC:
0.00756144
AN:
0.00756144
Heterozygous variant carriers
0
74
147
221
294
368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at